Ex-Novartis Exec Unveils Neurodegeneration Gene Therapy Start-Up AviadoBio
Lisa Deschamps Commercialized Novartis’s Zolgensma
Executive Summary
AviadoBio believes it can overcome barriers to making gene therapy work in neurodegenerative diseases, and its new CEO knows what it takes to make a commercial success in the field.